Anti-Tuberculosis Drug Resistant Rates inMycobacterium tuberculosisIsolated from Respiratory Specimens: A Multicenter Study in Korea | Zendy

Jayoung Kim | Zendy; Yeon-Joon Park | Zendy; Nam Yong Lee | Zendy; Chulhun L. Chang | Zendy; Miae Lee | Zendy; Jong Hee Shin | Zendy

Open Access

Anti-Tuberculosis Drug Resistant Rates inMycobacterium tuberculosisIsolated from Respiratory Specimens: A Multicenter Study in Korea

Author(s) -

Jayoung Kim,

Yeon-Joon Park,

Nam Yong Lee,

Chulhun L. Chang,

Miae Lee,

Jong Hee Shin

Publication year - 2013

Publication title -

annals of clinical microbiology

Language(s) - English

Resource type - Journals

eISSN - 2288-6850

pISSN - 2288-0585

DOI - 10.5145/acm.2013.16.1.1

Subject(s) - medicine , mycobacterium tuberculosis , tuberculosis , moxifloxacin , drug resistance , ofloxacin , antibiotics , microbiology and biotechnology , pathology , biology , ciprofloxacin

respectively, in new cases, and 21.7%, 13.0-17.4%, and 4.3%, respectively, in previously treated cases. In the previously treated cases, the proportions of XDR-TB in MDR-TB were 20% (3/15). The resistance rates were variable according to geographic location. Conclusion: As the anti-tuberculosis drug resistance rates are much higher in newly diagnosed cases than in previously treated patients, efforts should be made to ensure that tuberculosis treatment is successful. In addition, before the selection of an anti-tuberculosis drug treatment for previously treated patients, the susceptibility test results, including to fluoroquinolone, should be verified. (Ann Clin Microbiol 2013;16:1-7)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research